Zensar Technologies Limited — Important, 22-10-2024: Financial Result Updates

Zensar Technologies Limited's Board has approved the unaudited standalone and consolidated financial results for the quarter and half-year ending September 30, 2024. Key highlights include a revenue from operations of ₹5,562 million for the quarter and ₹10,858 million for the half-year. The company reported a net profit of ₹1,517 million for the quarter. Furthermore, Zensar has acquired a 100% stake in BridgeView Life Sciences, enhancing its capabilities in technology consulting for the biopharma sector.